JP2007527411A5 - - Google Patents

Download PDF

Info

Publication number
JP2007527411A5
JP2007527411A5 JP2006536832A JP2006536832A JP2007527411A5 JP 2007527411 A5 JP2007527411 A5 JP 2007527411A5 JP 2006536832 A JP2006536832 A JP 2006536832A JP 2006536832 A JP2006536832 A JP 2006536832A JP 2007527411 A5 JP2007527411 A5 JP 2007527411A5
Authority
JP
Japan
Prior art keywords
group
substituted
alkyl
independently selected
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006536832A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007527411A (ja
Filing date
Publication date
Priority claimed from US10/970,344 external-priority patent/US7297714B2/en
Application filed filed Critical
Publication of JP2007527411A publication Critical patent/JP2007527411A/ja
Publication of JP2007527411A5 publication Critical patent/JP2007527411A5/ja
Pending legal-status Critical Current

Links

JP2006536832A 2003-10-21 2004-10-21 カテプシンsの阻害剤 Pending JP2007527411A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51373503P 2003-10-21 2003-10-21
US10/970,344 US7297714B2 (en) 2003-10-21 2004-10-20 Inhibitors of cathepsin S
PCT/US2004/035062 WO2005039496A2 (en) 2003-10-21 2004-10-21 Inhibitors of cathepsin s

Publications (2)

Publication Number Publication Date
JP2007527411A JP2007527411A (ja) 2007-09-27
JP2007527411A5 true JP2007527411A5 (cg-RX-API-DMAC10.html) 2007-11-29

Family

ID=34526893

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006536832A Pending JP2007527411A (ja) 2003-10-21 2004-10-21 カテプシンsの阻害剤

Country Status (8)

Country Link
US (2) US7297714B2 (cg-RX-API-DMAC10.html)
EP (1) EP1677782A4 (cg-RX-API-DMAC10.html)
JP (1) JP2007527411A (cg-RX-API-DMAC10.html)
AU (1) AU2004283708B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0415824A (cg-RX-API-DMAC10.html)
CA (1) CA2542963A1 (cg-RX-API-DMAC10.html)
MX (1) MXPA06004440A (cg-RX-API-DMAC10.html)
WO (1) WO2005039496A2 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010507681A (ja) * 2006-10-23 2010-03-11 アイアールエム・リミテッド・ライアビリティ・カンパニー カテプシンプロテアーゼ阻害剤
US20160038600A1 (en) 2012-08-03 2016-02-11 Neonc Technologies Inc. Pharmaceutical compositions comprising poh derivatives
TWI402072B (zh) * 2010-10-19 2013-07-21 Lilly Co Eli 組織蛋白酶s抑制劑化合物
ES3056006T3 (en) * 2010-12-17 2026-02-17 Univ Southern California Methods and devices for using isoperillyl alcohol
AU2020250933A1 (en) 2019-04-05 2021-10-28 Centre Hospitalier Régional Et Universitaire De Brest Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756466A (en) * 1994-06-17 1998-05-26 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
JP3492703B2 (ja) * 1996-09-12 2004-02-03 アイドゥン ファーマシューティカルズ,インコーポレイテッド システインプロテアーゼのICE/ced―3ファミリーの阻害剤としてのC―末端変性(N―置換)―2―インドリルジペプチド
BR9911010A (pt) * 1998-05-05 2005-12-06 Warner Lambert Co Inibidores de sucinamida de enzima de conversão da interleucina-1beta
AU2560300A (en) * 1999-02-20 2000-09-04 Astrazeneca Ab Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsins
EA200100972A1 (ru) * 1999-03-15 2002-02-28 Аксис Фармасьютикалз, Инк. Новые соединения и композиции как ингибиторы протеаз
CA2369619A1 (en) 1999-04-09 2000-10-19 Cytovia, Inc. Caspase inhibitors and the use thereof
GB9911417D0 (en) * 1999-05-18 1999-07-14 Peptide Therapeutics Ltd Furanone derivatives as inhibitors of cathepsin s
DE60028045T2 (de) * 1999-07-30 2007-02-15 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Neue bernsteinsäure derivative als cysteine-protease-inhibitoren
HUP0302380A2 (hu) * 1999-09-13 2004-03-01 Boehringer Ingelheim Pharmaceuticals, Inc. Cisztein-proteázok reverzibilis inhibitoraiként alkalmazható új spiroheterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
CO5280088A1 (es) * 2000-04-18 2003-05-30 Smithkline Beecham Corp Inhibidores de proteasa
IL155961A0 (en) * 2000-11-17 2003-12-23 Medivir Uk Ltd Cysteine protease inhibitors
EP1341767B1 (en) 2000-11-21 2007-04-11 Vertex Pharmaceuticals Incorporated Imidazole and benzimidazole caspase inhibitors and uses thereof
US6982263B2 (en) * 2001-06-08 2006-01-03 Boehringer Ingelheim Pharmaceuticals, Inc. Nitriles useful as reversible inhibitors of cysteine proteases
US20030144234A1 (en) * 2001-08-30 2003-07-31 Buxton Francis Paul Methods for the treatment of chronic pain and compositions therefor
US6900237B2 (en) * 2001-09-14 2005-05-31 Axys Pharmaceuticals, Inc. Sulfonamide compounds as protease inhibitors
WO2003031437A1 (en) * 2001-10-09 2003-04-17 Smithkline Beecham Corporation Propylcarbamate derivatives as inhibitors of serine and cysteine proteases

Similar Documents

Publication Publication Date Title
TWI600638B (zh) 作爲蛋白質去乙醯酶抑制劑之反式醯胺化合物及其使用方法
US10905665B2 (en) Chemical modulators of signaling pathways and therapeutic use
WO1993003013A1 (fr) Derives d'indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant
RS56717B1 (sr) Derivati dolastatina 10 i auristatina
JP4417551B2 (ja) ヘミアスターリン類似体
CA2327282A1 (en) Treatment of parasitic diseases by inhibition of cysteine proteases of the papain superfamily
KR20210102887A (ko) 말초 세로토닌과 관련된 질병 또는 장애를 치료하기 위한 트립토판 하이드록실라제 1 (tph1)의 결정질 스피로사이클릭 화합물 억제제
JPH08508720A (ja) ピロールーアミジン化合物およびその薬剤的に受容できる塩、その製造法ならびにこれを含む医薬組成物
JP2002503714A (ja) 抗腫瘍剤
JPH05140063A (ja) ジペプチド誘導体及びそれを有効成分とする骨疾患の予防及び治療剤
CZ159197A3 (cs) Inhibitory metalloproteinázy, způsob jejich výroby a farmaceutický prostředek s jejich obsahem
SG11202110271TA (en) Inhibitors of the n-terminal domain of the androgen receptor
US7304088B2 (en) Protease inhibitors
EA001863B1 (ru) Акрилоилзамещенные производные дистамицина, способы их получения, применение в качестве противоопухолевых средств и фармкомпозиции
WO2006043655A1 (ja) 吸入用医薬組成物
JPH06192199A (ja) ケトン誘導体
WO2024089159A1 (en) Main protease inhibitors
JP4604161B2 (ja) フェニルアラニン誘導体
JP7442192B2 (ja) がん特異的酵素活性を利用したプロドラッグ型抗がん剤
WO2019063955A1 (fr) Agents inhibant la proteine tctp pour le traitement de maladies proliferatives, de maladies infectieuses, d'allergies, d'inflammations et/ou de l'asthme
JP2024526865A (ja) 腎癌の標的治療のための新規化合物及び組成物
CN109476605B (zh) 具有抗肿瘤活性的苯并-n-羟基酰胺化合物
US20070082922A1 (en) Huperzine a prodrugs and uses thereof
US11149062B2 (en) HDAC inhibitors and methods of treatment using the same
JPS61122296A (ja) 新規5‐アミノ‐4‐ヒドロキシバレリル誘導体